Britain doubles down on the life-sciences industry

The UK government vows to support the growth of the life-sciences industry, but startups still face challenges in clinical trials, funding, and market size.

August 10, 2023 . 5:05 AM

1 min read

The UK government is committed to supporting the growth of the life-sciences industry.
The sector has gained prominence during the COVID-19 pandemic.
Challenges for startups include slow clinical trial processes, high property costs, and difficulty in raising large-scale capital.
The government is taking steps to address these challenges, including improving trial efficiency and attracting private-sector capital.
However, the UK faces challenges such as a small market size, NHS drug-pricing policies, and declining exports.